Long-term effect of deslorelin implant on ovarian pre-antral follicles and uterine histology in female rats

Reproduction in Domestic Animals

Volumn 48, Issue 2, 2013, Pages 195-199

  Cetin, Y ^a   Alkis, I ^b   Sendag, S ^c   Ragbetli, M ^c   Akyol, V ^c   Ucar, O ^d   Wehrend, A ^e  

^a MEHMET AKIF ERSOY UNIVERSITY   (Turkey)

^b Bakirkoy Maternity and Children's Diseases Education and Research Hospital   (Turkey)

^c YUZUNCU YIL UNIVERSITY   (Turkey)

^d ATATÜRK UNIVERSITY   (Turkey)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DESLORELIN; DRUG DERIVATIVE; ENZYME INHIBITOR; GONADORELIN; TRIPTORELIN;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG IMPLANT; DRUG POTENTIATION; FEMALE; HISTOLOGY; MALE; OVARY FOLLICLE; PREGNANCY; RAT; UTERUS; WISTAR RAT;

ANIMALS; DRUG IMPLANTS; ENZYME INHIBITORS; FEMALE; GONADOTROPIN-RELEASING HORMONE; MALE; OVARIAN FOLLICLE; PREGNANCY; RATS; RATS, WISTAR; TRIPTORELIN PAMOATE; UTERUS;

ANIMALIA; RATTUS;

EID: 84875051344     PISSN: 09366768     EISSN: 14390531     Source Type: Journal    
DOI: 10.1111/j.1439-0531.2012.02128.x     Document Type: Article

References (29)

1. Alkis I, Cetin Y, Sendag S, Wehrend A, 2011: Long term suppression of oestrus and prevention of pregnancy by deslorelin implant in rats. B Vet I Pulawy55, 237-240.
2. Child TJ, Sylvestre C, Tan SL, 2002: Endometrial volume and thickness measurements predict pituitary suppression and non-suppression during IVF. Hum Reprod17, 3110-3113.
3. Cruzorive LM, Weibel ER, 1990: Recent stereological methods for cell biology: a brief survey. Am J Physiol258, 148-156.
4. Goericke-Pesch S, Spang A, Schulz M, Ozalp G, Bergmann M, Ludwig C, Hoffmann B, 2009: Recrudescence of spermatogenesis in the dog following downregulation using a slow release GnRH agonist implant. Reprod Domest Anim44, 302-308.
5. Goericke-Pesch S, Georgiev P, Antonov A, Albouy M, Wehrend A, 2011: Clinical efficacy of a GnRH-agonist implant containing 4.7mg deslorelin, Suprelorin, regarding suppression of reproductive function in tomcats. Theriogenology75, 803-810.
6. Gundersen HJG, Jensen EB, 1987: The efficiency of systematic sampling in stereology and its prediction. J Microsc147, 229-263.
7. Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, West MJ, 1988: Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Apmis96, 379-394.
8. Gungor O, Pancarci SM, Cenesiz M, Beceriklisoy HB, Kanca H, 2007: Effect of GnRH implant (deslorelin) with different formulation on fertility and delay of oestrous cycle in ewes. B Vet I Pulawy51, 25-29.
9. Irusta G, Parborell F, Peluffo M, Manna PR, Gonzalez-Calvar SI, Calandra R, Stocco DM, Tesone M, 2003: Steroidogenic acute regulatory protein in ovarian follicle of Gonadotropin-stimulated rats is regulated by a Gonadotropin- Releasing Hormone Agonist. Biol Reprod68, 1577-1583.
10. Junaidi A, Williamson PE, Martin GB, Blackberry MA, Cummins JM, Trigg TE, 2009: Dose-response studies for pituitary and testicular function in male dogs treated with the GnRH superagonist, deslorelin. Reprod Domest Anim44, 725-734.
11. Kaplan S, Gökyar A, Ünal B, Turkkani-Tunç A, Bahadir A, Aslan H, 2005: A simple technique for localizing consecutive fields for disector pairs in light microscopy: application to neuron counting in rabbit spinal cord following spinal cord injury. J Neuroscience Methods145, 277-284.
12. ®) on sexual function in boars. Theriogenology74, 733-740.
13. Krishna A, Srivastava RK, Sridaran R, 1996: Effects of short-term treatment of a gonadotropin-releasing hormone agonist on the follicular development and gonadotropin secretion in the rat. Endocr Res22, 299-310.
14. Lehrer SB, Tekeli S, Fort FL, Cusick PK, Krasula RW, Patterson DR, 1992: Effects of a GnRH agonist on fertility following administration to prepubertal male and female rats. Fund Appl Toxicol19, 101-108.
15. Leiberman JR, Wiznitzer A, Glezerman M, Feldman B, Levy J, Sharoni Y, 1993: Estrogen and progesterone receptors in the uterine artery of rats during and after pregnancy. Eur J Obstet Gynecol Reprod Biol51, 35-40.
16. Luna LG, 1968: Armed Forces Institute of Pathology: Manual of Histologic Staining Methods, 3rd edn. MacGraw-Hill, New York.
17. Mattos R, Orlandi C, Williams J, Staples CR, Trigg T, Thatcher WW, 2001: Effect of an implant containing the GnRH agonist deslorelin on secretion of LH, ovarian activity and milk yield of postpartum dairy cows. Theriogenology56, 371-386.
18. Norwitz ER, Jeong KH, Chin WW, 1999: Molecular mechanisms of gonadotropin-releasing hormone receptor gene regulation. J Soc Gynecol Invest6, 169-178.
19. Parborell F, Pecci A, Gonzalez O, Vitale A, Tesone M, 2002: Effects of a gonadotropin-releasing hormone agonist on rat ovarian follicle apoptosis: regulation by epidermal growth factor and the expression of Bcl-2-related genes. Biol Reprod67, 481-486.
20. Parborell F, Irusta G, Vitale A, Gonzalez O, Pecci A, Tesone M, 2005: Gonadotropin-releasing hormone antagonist antide inhibits apoptosis of preovulatory follicle cells in rat ovary. Biol Reprod72, 659-666.
21. Peng C, Fan NC, Ligier M, Vaananen J, Leung PCK, 1994: Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology135, 1740-1746.
22. Rajamahendran R, Ambrose JD, Schmitt EJP, Thatcher MJ, Thatcher WW, 1998: Effects of buserelin injection and deslorelin (GnRH-agonist) implants on plasma progesterone, LH, accessory CL formation, follicle and corpus luteum dynamics in Holstein cows. Theriogenology50, 1141-1155.
23. Romagnoli S, Stelletta C, Milani C, Gelli D, Falomo ME, Mollo A, 2009: Clinical use of deslorelin for the control of reproduction in the bitch. Reprod Domest Anim44(Suppl 2), 36-39.
24. Roth C, Schricker M, Lakomek M, Strege A, Heiden I, Luft H, Munzel U, Wuttke W, Jarry H, 2001: Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic vs agonistic GnRH analogs in a female rat model. J Endocrinol169, 361-371.
25. Singh P, Krishna A, 2010: Effects of GnRH agonist treatment on steroidogenesis and folliculogenesis in the ovary of cyclic mice. J Ovarian Res3, 26.
26. Srivastava RK, Krishna A, Sridaran R, 1995: Follicular development, steroidogenesis and gonadotrophin secretion in response to long-term treatment with a gonadotrophin-releasing hormone agonist in the rat. J Endocrinol146, 349-357.
27. Takeyoshi M, Sawaki M, Noda S, Muroi T, Yamasaki K, 2002: Effect of gonadotropin-releasing hormone antagonist on ovarian and uterine weights in immature female rats. Reprod Toxicol16, 367-369.
28. Toydemir TS, Kilicarslan MR, Olgac V, 2011: Effects of the GnRH analogue deslorelin implants on reproduction in female domestic cats. Theriogenology77, 662-674.
29. Trigg TE, Wright PJ, Armour AF, Williamson PE, Junaidi A, Martin GB, Doyle AG, Walsh J, 2001: Use of a GnRH analogue implant to produce reversible long-term suppression of reproductive function in male and female domestic dogs. J Rep Fer Suppl57, 255-261.